Fachrepositorium Lebenswissenschaften

6 Treffer

Suche

Publisso-Menue

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial

2021 . Christopoulos, Petros | Bozorgmehr, Farastuk | Brückner, Lena | Chung, Inn | Krisam, Johannes | Schneider, Marc A. | Stenzinger, Albrecht | Eickhoff, Regina | Mueller, Daniel W. | Thomas, Michael

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

2021 . Angeles, Arlou Kristina | Christopoulos, Petros | Yuan, Zhao | Bauer, Simone | Janke, Florian | Ogrodnik, Simon John | Reck, Martin | Schlesner, Matthias | Meister, Michael | Schneider, Marc A. | Dietz, Steffen | Stenzinger, Albrecht | Thomas, Michael | Sültmann, Holger

Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report

2021 . Blasi, Miriam | Kazdal, Daniel | Thomas, Michael | Christopoulos, Petros | Kriegsmann, Mark | Brandt, Regine | Volckmar, Anna-Lena | Kirchner, Martina | Heußel, Claus Peter | Stenzinger, Albrecht | Kuon, Jonas

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

2020 . Bozorgmehr, Farastuk | Chung, Inn | Christopoulos, Petros | Krisam, Johannes | Schneider, Marc A. | Brückner, Lena | Mueller, Daniel Wilhelm | Thomas, Michael | Rieken, Stefan